Neuropsychological assessment of patients with relapsing remitting multiple sclerosis prior to the use of immunomodulatory drugs Evaluación neuropsicológica en 129 pacientes chilenos con esclerosis múltiple recurrente remitente previo a inicio de fármacos
Author
dc.contributor.author
Nogales-Gaete, Jorge
Author
dc.contributor.author
Aracena, Rodrigo
Author
dc.contributor.author
Díaz, Vannia
Author
dc.contributor.author
Zitko, Pedro
Author
dc.contributor.author
Eloiza, Claudio
Author
dc.contributor.author
Cepeda-Zumaeta, Sergio
Author
dc.contributor.author
Agurto, Paula
Author
dc.contributor.author
González, Carola
Admission date
dc.date.accessioned
2019-03-15T16:04:28Z
Available date
dc.date.available
2019-03-15T16:04:28Z
Publication date
dc.date.issued
2012
Cita de ítem
dc.identifier.citation
Revista Medica de Chile, Volumen 140, Issue 11, 2018, Pages 1437-1444
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.issn
07176163
Identifier
dc.identifier.other
10.4067/S0034-98872012001100009
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165982
Abstract
dc.description.abstract
Background: The detection of cognitive changes (CC) and psychiatric disorders in relapsing remitting multiple sclerosis (MS-RR) contributes to patient clinical monitoring. Aim: To assess the frequency and characteristics of CC and psychiatric disorders in Chilean patients with MS-RR, before starting immunomodulatory treatment. Patients and Methods: Retrospective review of data that was obtained following a standard assessment protocol. It consisted in the application of the Expanded Disability Status Scale of Kurtzke (EDSS), Multiple Sclerosis Functional Composite (MSFC), fatigue intensity scale of Krupp, brief repeatable battery of neuropsychological Rao (BRN-R) and Hamilton ́s depression and anxiety questionnaires. Results: We evaluated 129 patients aged between 12 and 60 years of age (69% women). Ninety four percent of patients had eight or more years of schooling. The average EDSS score was 2.83. CC were detected in 62% of participants, in at least one subtest of the BRN-R. The mai
Neuropsychological assessment of patients with relapsing remitting multiple sclerosis prior to the use of immunomodulatory drugs Evaluación neuropsicológica en 129 pacientes chilenos con esclerosis múltiple recurrente remitente previo a inicio de fármacos